Aerobic Exercise for Urinary Incontinence in Multiple Sclerosis
UI-MS
Aerobic Exercise as a Therapeutic Approach for Urinary Incon-tinence in Multiple Sclerosis: Insights From a Pilot Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
Limited studies has investigated the effect of aerobic exercise program on urinary inconitenance in people with multiple sclerosis. This study aims to explore the effects of a six weeks moderate-intensity aerobic exercise intervention on UI and UI related bi-omarkers specifically cortisol using. Urinary incontinence and blood samples were assessed after 6-week intervention of aerobic exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 17, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedFebruary 25, 2025
February 1, 2025
1.1 years
February 17, 2025
February 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incontinence Questionnaire short-form ques-tionnaire (ICIQ-UI SF)
The International Consultation on Incontinence Questionnaire short-form ques-tionnaire (ICIQ-UI SF) was used to assess the presence and frequency of UI in our pa-tient cohort. The questionnaire has been validated and widely used in clinical and re-search settings to evaluate urinary symptoms and quality of life. It serves as a valuable tool for healthcare providers and researchers in evaluating the prevalence, frequency, severity, and the impact of UI on the quality of life (QoL) of individuals affected by this neurological condition as per MS. The Arabic version of the ICIQ\_UI\_SF was used in this study. The total ICIQ-UI SF score ranges from 0 to 21 points, with the severity being classified according to the total score: 0-7 points for mild UI, 8-12 points for moderate UI, and 13-21 points for severe UI.
6 Weeks
Secondary Outcomes (1)
Plasma Cortisol level
6 Weeks
Study Arms (2)
Moderate-Intensity Aerobic Exercise group (MIAE)
EXPERIMENTALParticipants in the moderate-intensity aerobic exercise (MIAE) group engaged in a 40-minute supervised session using the StepOne-SCIFIT recumbent stepper machine. The session included a 5-minute warm-up at 25 watts, followed by 30 minutes of moderate-intensity exercise, main-taining a stepping rate of 90-100 steps per minute. The workload was adjusted to keep the participant's heart rate within the target heart rate range (THRR), calculated using the Karvonen formula. During the first three weeks, the exercise intensity was set at 50-59% of heart rate reserve (HRR), and for the remaining three weeks, it was increased to 60-69% of HRR. Polar heart rate monitors were used to assess heart rate before and after each session. Participants kept weekly exercise logs to monitor compliance.
Home Exercise Program group (HEP)
ACTIVE COMPARATORParticipants in the home exercise program (HEP) group received a Digital video disc (DVD) exercise and a printed manual covering low-intensity, non-aerobic exercises to control for general activity levels. The DVD, developed for individuals with movement disorders, was in Arabic and included warm-up and cool-down activities, flexibility, strength, balance, endurance exercises, and relaxation techniques. The examiner reviewed the DVD and precautions with each participant to ensure correct execution. Participants were also monitored for adherence through weekly exercise logs.
Interventions
Participants in the MIAE group engaged in a 40-minute supervised session using the StepOne-SCIFIT recumbent stepper machine. The session included a 5-minute warm-up at 25 watts, followed by 30 minutes of moderate-intensity exercise, main-taining a stepping rate of 90-100 steps per minute. The workload was adjusted to keep the participant's heart rate within the target heart rate range (THRR), calculated using the Karvonen formula. During the first three weeks, the exercise intensity was set at 50-59% of heart rate reserve (HRR), and for the remaining three weeks, it was increased to 60-69% of HRR. Polar heart rate monitors were used to assess heart rate before and after each session. Participants kept weekly exercise logs to monitor compliance.
Eligibility Criteria
You may qualify if:
- Confirmed MS diagnosis by a neurologist based on the revised McDonald criteria.
- Expanded Disability Status Scale (EDSS) score between 3 and 5.5
- No symptom exacerbation in the 30 days before testing
- Aged 18 years or older
- Ability to provide informed consent
- Absence of urinary incontinence (UI) before MS onset
- no history of pelvic surgery, radiotherapy, or bladder stones.
You may not qualify if:
- Inability to perform the exercise test on a recumbent stepper
- Recent acute ischemic cardiovascular event or coronary artery bypass surgery within the past three months
- severe uncorrected visual impairments
- Uncontrolled hy-pertension (blood pressure \> 190/110 mmHg) despite medication.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Naseem Oudah
Irbid, 22110, Jordan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate prof
Study Record Dates
First Submitted
February 17, 2025
First Posted
February 25, 2025
Study Start
November 1, 2018
Primary Completion
December 1, 2019
Study Completion
May 1, 2020
Last Updated
February 25, 2025
Record last verified: 2025-02